Lowell I. Dashefsky is a partner in the Corporate Department of the New York office of Kaye Scholer LLP. Lowell’s practice focuses on corporate transactions, including mergers and acquisitions, private equity investments, joint ventures, strategic alliances and complex intellectual property licensing arrangements. He also has experience in public and private securities offerings, and regularly advises companies of various sizes on day-to-day general corporate and transactional matters.
Lowell represents a variety of domestic and foreign publicly held and private companies in various industries, including companies in the private equity, finance, pharmaceutical, biotechnology, real estate, infrastructure, defense, consumer products, information technology, medical devices and healthcare service industries.
Lowell is recognized for mergers and acquisitions by leading surveys such as IFLR1000 and The Legal 500 US.
In The Market
- Kaye Scholer Advises Pfizer in Acquisition of Bamboo Therapeutics August 1, 2016 • 新闻公告
- Kaye Scholer Represents 328 Group in Sale of Aviation Companies to SN February 2, 2015 • 新闻公告
- Kaye Scholer Represents Pfizer in Acquisition of InnoPharma July 16, 2014 • 新闻公告